ライフサイエンスツールの北米市場2020-2027:エンドユーザー別、技術別、製品別

Table of Contents

Chapter 1 Methodology and Scope
1.1 Research Assumptions
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Sample size for the study on North America Life Science Tools market:
1.3.1.1 Primary Sources
1.3.1.1.1 Details of Primary Research
1.3.1.2 Secondary Data Sources
1.4 Information or Data Analysis
1.5 Market Formulation & Validation
1.6 Market Model
1.6.1 Nucleic Acid Preparation market
1.6.2 Cell biology market
1.6.2.1 Comparison of 3D cell culture techniques
1.6.3 Next – Generation Sequencing & Transfection Electroporation market
1.6.4 Market study, by Technology
1.6.5 QFD modeling for market share assessment of technologies
1.6.6 Market study, by end use
1.7 Global Market: CAGR Calculation
1.8 Objectives
1.8.1 Objective 1
1.8.2 Objective 2
Chapter 2 Executive Summary
2.1 Market Summary, 2019
Chapter 3 Market Variables, Trends, & Scope
3.1 Market Dynamics
3.1.1 Market driver analysis
3.1.1.1 Increased government funding for life science technologies
3.1.1.2 Growth of cell and gene therapies
3.1.1.3 Rise in demand for biopharmaceuticals (biologics and biosimilars)
3.1.1.4 Technological advancements in life science tools
3.1.1.5 Applications of genomic and proteomic technologies for precision medicine
3.1.2 Market restraint analysis
3.1.2.1 High cost for some technologies
3.1.2.2 Dearth of skilled professionals
3.1.3 Market opportunity analysis
3.1.3.1 Rise in the number of strategic deals & developments
3.2 Penetration and Growth Prospect Mapping for Technology, 2019 (USD Million)
3.3 Impact of COVID – 19 pandemic on North America Life Science Tools Market
3.3.1 Impact on the supply chain
3.3.2 Impact on life sciences & healthcare industry
3.4 Market Share Analysis
3.4.1 Company Size
3.4.2 Product portfolio
3.4.3 Strategic Initiatives
3.5 Business Environment Analysis
3.5.1 SWOT Analysis; By factor (Political & Legal, Economic, and Technological)
3.5.2 Porter’s Five Forces Analysis
Chapter 4 Technology Movement Analysis
4.1 Market: Technology Movement Analysis
4.2 Genomic Technology
4.2.1 Market estimates and forecast, 2016 – 2027 (USD Million)
4.3 Proteomics Technology
4.3.1 Market estimates and forecast, 2016 – 2027 (USD Million)
4.4 Cell Biology Technology
4.4.1 Market estimates and forecast, 2016 – 2027 (USD Million)
4.5 Other Analytical & Sample Preparation Technology
4.5.1 Market estimates and forecast, 2016 – 2027 (USD Million)
4.6 Lab Supplies & Technologies
4.6.1 Market estimates and forecast, 2016 – 2027 (USD Million)
Chapter 5 Product Business Analysis
5.1 North America Life Science Tools Market: Product Movement Analysis
5.2 Next – Generation Sequencing
5.2.1 Market estimates and forecast for NGS, 2016 – 2027 (USD Million)
5.2.2 Instruments
5.2.3 Consumables
5.2.4 Services
5.3 PCR & qPCR
5.3.1 Market estimates and forecast for PCR & qPCR, 2016 – 2027 (USD Million)
5.3.2 Instruments
5.3.3 Consumables
5.3.4 Services
5.4 Flow Cytometry
5.4.1 Market for flow cytometry, 2016 – 2027 (USD Million)
5.4.2 Instruments
5.4.3 Consumables
5.4.4 Services
5.5 Nuclear Magnetic Resonance Spectroscopy (NMR)
5.5.1 Market for Nuclear magnetic resonance spectroscopy, 2016 – 2027 (USD Million)
5.5.2 Instruments
5.5.3 Consumables
5.5.4 Services
5.6 Microscopy & Electron Microscopy
5.6.1 Market for microscopy & electron microscopy, 2016 – 2027 (USD Million)
5.6.2 Instruments
5.6.3 Consumables
5.6.4 Services
5.7 Liquid Chromatography (LC)
5.7.1 Market for liquid chromatography, 2016 – 2027 (USD Million)
5.7.2 Instruments
5.7.3 Consumables
5.7.4 Services
5.8 Mass Spectrometry (MS)
5.8.1 Market for mass spectrometry, 2016 – 2027 (USD Million)
5.8.2 Instruments
5.8.3 Consumables
5.8.4 Services
5.9 Nucleic Acid Preparation (NAP)
5.9.1 Market for nucleic acid preparation, 2016 – 2027 (USD Million)
5.9.2 Instruments
5.9.3 Consumables
5.9.4 Services
5.10 Transfection Electroporation
5.10.1 Market for transfection electroporation, 2016 – 2027 (USD Million)
5.10.2 Equipment
5.10.3 Reagents
5.11 Cell Biology
5.11.1 Market for cell biology, 2016 – 2027 (USD Million)
5.11.2 Instruments
5.11.2.1 Glassware
5.11.2.2 Culture ware
5.11.2.3 Others
5.11.3 Consumables
5.11.3.1 Media & sera
5.11.3.2 Reagents
5.11.4 Cell & tissue culture services
5.12 Cloning
5.12.1 Market for cloning, 2016 – 2027 (USD Million)
5.12.2 Kits, reagents, and consumables
5.12.3 Services
5.13 Other products & services
5.13.1 Market for other products & services, 2016 – 2027 (USD Million)
5.13.2 Antibodies
5.13.3 General supplies
5.13.4 Nucleic Acid Microarray
5.13.4.1 Instruments
5.13.4.2 Consumables
5.13.4.3 Services
5.13.5 Others
5.13.5.1 Market for others, 2016 – 2027 (USD Million)
5.13.5.2 Instruments
5.13.5.3 Consumables
5.13.5.4 Services
Chapter 6 End – use Movement Analysis
6.1 Market: End – use Movement Analysis
6.2 Government & Academic
6.2.1 Market for government & academic end use, 2016 – 2027 (USD Million)
6.3 Biopharmaceutical Company
6.3.1 Market for biopharmaceutical companies, 2016 – 2027 (USD Million)
6.4 Healthcare
6.4.1 Market for health care end use, 2016 – 2027 (USD Million)
6.5 Industrial Application
6.5.1 Market for industrial application, 2016 – 2027 (USD Million)
6.6 Others
6.6.1 Market for others end use, 2016 – 2027 (USD Million)
Chapter 7 Regional Movement Analysis
7.1 Market: Regional Movement Analysis
7.2 U.S.
7.2.1 Market estimates and forecast, by technology, 2016 – 2027 (USD Million)
7.2.2 Market estimates and forecast, by product, 2016 – 2027 (USD Million)
7.2.3 Market estimates and forecast, by end – use, 2016 – 2027 (USD Million)
7.3 Canada
7.3.1 Market estimates and forecast, by technology, 2016 – 2027 (USD Million)
7.3.2 Market estimates and forecast, by product, 2016 – 2027 (USD Million)
7.3.3 Market estimates and forecast, by end – use, 2016 – 2027 (USD Million)
Chapter 8 Company Profile
8.1 Company Profiles
8.1.1 Thermo Fisher Scientific, Inc.
8.1.1.1 Company Overview
8.1.1.1.1 Life Technologies Corp
8.1.1.2 Financial Performance
8.1.1.3 Product Benchmarking
8.1.1.4 Strategic Initiatives
8.1.2 F. Hoffmann – La Roche Ltd.
8.1.2.1 Company Overview
8.1.2.2 Financial Performance
8.1.2.3 Product Benchmarking
8.1.2.4 Strategic Initiatives
8.1.3 Illumina, Inc.
8.1.3.1 Company Overview
8.1.3.2 Financial Performance
8.1.3.3 Product Benchmarking
8.1.3.4 Strategic Initiatives
8.1.4 Agilent Technologies
8.1.4.1 Company Overview
8.1.4.2 Financial Performance
8.1.4.3 Product Benchmarking
8.1.4.4 Strategic Initiatives
8.1.5 Becton, Dickinson and Company (BD)
8.1.5.1 Company Overview
8.1.5.2 Financial Performance
8.1.5.3 Product Benchmarking
8.1.5.4 Strategic Initiatives
8.1.6 Bio – Rad Laboratories, Inc.
8.1.6.1 Company Overview
8.1.6.1.1 GnuBio
8.1.6.2 Financial Performance
8.1.6.3 Product Benchmarking
8.1.6.4 Strategic Initiatives
8.1.7 Danaher Corporation
8.1.7.1 Company Overview
8.1.7.1.1 Beckman Coulter, Inc.
8.1.7.1.2 Pall Corporation
8.1.7.2 Financial Performance
8.1.7.3 Product Benchmarking
8.1.7.4 Strategic Initiatives
8.1.8 General Electric Company
8.1.8.1 Company Overview
8.1.8.2 Financial Performance
8.1.8.3 Product Benchmarking
8.1.8.4 Strategic Initiatives
8.1.9 Merck KGaA
8.1.9.1 Company Overview
8.1.9.1.1 Sigma – Aldrich Co. LLC
8.1.9.1.2 Merck Millipore
8.1.9.2 Financial Performance
8.1.9.3 Product Benchmarking
8.1.9.4 Strategic Initiatives
8.1.10 QIAGEN
8.1.10.1 Company Overview
8.1.10.1.1 Ingenuity
8.1.10.1.2 CLC Bio
8.1.10.1.3 Exiqon
8.1.10.2 Financial Performance
8.1.10.3 Product Benchmarking
8.1.10.4 Strategic Initiatives
8.1.11 Corning Incorporated
8.1.11.1 Company Overview
8.1.11.2 Financial Performance
8.1.11.3 Product Benchmarking
8.1.11.4 Strategic Initiatives
8.1.12 Perkin Elmer, Inc.
8.1.12.1 Company Overview
8.1.12.2 Financial Performance
8.1.12.3 Product Benchmarking
8.1.12.4 Strategic Initiatives
8.1.13 Miltenyi Biotec
8.1.13.1 Company Overview
8.1.13.2 Financial Performance
8.1.13.3 Product Benchmarking
8.1.13.4 Strategic Initiatives
8.1.14 Bruker
8.1.14.1 Company Overview
8.1.14.2 Financial Performance
8.1.14.3 Product Benchmarking
8.1.14.4 Strategic Initiatives
8.1.15 Hitachi Koki Co., Ltd.
8.1.15.1 Company Overview
8.1.15.2 Financial Performance
8.1.15.3 Product Benchmarking
8.1.15.4 Strategic Initiatives
8.1.16 Shimadzu Corporation
8.1.16.1 Company Overview
8.1.16.2 Financial Performance
8.1.16.3 Product Benchmarking
8.1.16.4 Strategic Initiatives
8.1.17 Oxford Instruments
8.1.17.1 Company Overview
8.1.17.2 Financial Performance
8.1.17.3 Product Benchmarking
8.1.17.4 Strategic Initiatives

グローバル市場調査会社